Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

ClinicalTrials.gov ID: NCT03039634

Public ClinicalTrials.gov record NCT03039634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 2, 2026, 3:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-blind, Nontreatment, Long-term, Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA of a Topical Silver Particle Solution Followed by Laser for the Treatment of Facial Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a laser for the treatment of Acne Vulgaris.

Study identification

NCT ID
NCT03039634
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Sienna Labs
Industry
Enrollment
76 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2016 (Type not available)
Primary completion
May 2018 (Actual)
Completion
May 2018 (Actual)
Last update posted
Mar 4, 2019

2016 – 2018

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Not listed Scottsdale Arizona 85255 —
Not listed Santa Monica California 90404 —
Not listed Coral Gables Florida 33146 —
Not listed Miami Florida 33173 —
Not listed Hunt Valley Maryland 21030 —
Not listed Beverly Massachusetts 01915 —
Not listed St Louis Missouri 92691 —
Not listed Hackensack New Jersey 07601 —
Not listed Charlotte North Carolina 28207 —
Not listed Yardley Pennsylvania 19067 —
Not listed Charleston South Carolina 29414 —
Not listed Houston Texas 77030 —
Not listed Pflugerville Texas 78660 —
Not listed San Antonio Texas 78229 —
Not listed Jordan Utah 84088 —
Not listed Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03039634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 4, 2019 · Synced Oct 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03039634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →